ANTARES PHARMA, INC.·4

Feb 12, 6:53 PM ET

GARRITY THOMAS J 4

4 · ANTARES PHARMA, INC. · Filed Feb 12, 2021

Insider Transaction Report

Form 4
Period: 2021-02-11
Transactions
  • Exercise/Conversion

    Common Stock

    2021-02-11$1.12/sh+50,000$56,000274,406 total
  • Sale

    Common Stock

    2021-02-11$4.62/sh50,000$231,000224,406 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-02-1150,0000 total
    Exercise: $1.12Exp: 2026-06-02Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]The options vested and became exercisable in four equal quarterly installments from the grant date of June 2, 2016.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION